Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons
Open Access
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 76, 126-138
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation (PG/13/8/29989)
This publication has 86 references indexed in Scilit:
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Interleukin-1R3 mediates interleukin-1–induced potassium current increase through fast activation of Akt kinaseProceedings of the National Academy of Sciences, 2012
- Interleukin‐1 Mediates Neuroinflammatory Changes Associated With Diet‐Induced AtherosclerosisJournal of the American Heart Association, 2012
- The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the ratBrain Stimulation, 2012
- TAK1 in brain endothelial cells mediates fever and lethargyJournal of Experimental Medicine, 2011
- Laser Speckle Contrast Imaging of Cerebral Blood FlowAnnals of Biomedical Engineering, 2011
- Ischaemic stroke: a thrombo‐inflammatory disease?The Journal of Physiology, 2011
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Endothelial IL-1R1 is a critical mediator of EAE pathogenesisBrain, Behavior, and Immunity, 2011
- Interleukin‐1‐induced interleukin‐6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neuronesBritish Journal of Pharmacology, 2008